SAMHIC Member
 
SAMHIC Member  
Members
SAMHIC Member
New Hope Group Co., Ltd.

New Hope Group Co., Ltd. was founded in 1982 and it has being among the top 500 Chinese enterprises for 12 years. Currently, the group has more than 600 domestic and foreign subsidiaries in 30 countries, with over 80,000 employees and a sales revenue of over 90 billion yuan. It is involved in four industries, including farming and food, chemicals and resources, real estate and infrastructure, finance and investment.

New Hope Group is one of the first Chinese private enterprises to go abroad. Since the first factory was built in Vietnam in 1997, it has invested in more than 50 business or factory through direct establishment, mergers & acquisitions, and cooperation in many countries, such as the United States, Australia, New Zealand, Russia, South Africa and Indonesia.

Greatcity Investment Co., Ltd.

Greatcity Corporation (affiliated to Vantone Holdings Co., Ltd.) is founded by Feng Lun and originally invested mainly by Liu Yonghao and Wang Bing. With a mission to be the "pioneer of ideal city" and a vision and core concept of " building a micro-city and creating a better life of city-industry integration, intensive land use, green intelligence, smart growth and social harmony", this enterprise has built six supported platforms on financial services, planning and designing, medical and pension industry, virtual development, R&D of smart growth and project management. With the medical & healthcare industry as the core industry, the Great City project involves a whole industry chain integrated with medical services, healthcare, education, research and trade and balances its functions of business services, basic education, urban agriculture and residence in a reasonable way. The ideal model of the Great City is a construction with a building area of 3,000,000 m2 - 5,000,000 m2 (within one square kilometer's net construction land), holding about 30,000 to 50,000 residents among which half of the labor force is employed in the city. This is the ideal city in line with the new pattern of urbanization.

Taikang Community Investment Co., Ltd.

Taikang Community Investment Co., Ltd. is a wholly-owned subsidiary of Taikang Life Insurance Co., Ltd. specializing in the medical and pension industry and real estate investment and operation management with assets under management of more than 40 billion yuan. It is not only a vertically integrated company with the medical and pension industry as its core and the high-end commercial real estate as its feature, but also a professional corporation of a whole industry chain with a strong capability of investment, planning and designing, nursing service, hospital management, investment attraction & leasing and property management. At present, we have completed the layout of the flagship "vibrant communities on medical and health care" in Beijing, Shanghai, Guangzhou, Sanya and Suzhou, with an area of medical and healthcare property of about 1 million square meters. Besides, it has initially set up medical centers, rehabilitation and geriatric hospital chains integrated with "medical service, teaching and research" and established a Taikang medical system with the core city's high-end clinics as the main part.

Vanhal International Group Co., Ltd.

Vanhal International Group was established in 1995, owning two listed companies in Hong Kong. In 2006, in the face of China's vast market and great potential prospects of medical industry, Vanhal International Group decided to enter the medical sector. Therefore, Huaxia Healthcare Holdings Co., Ltd. (8143.HK) was established in Hong Kong through mergers and acquisitions, cooperation, trusteeship or new construction. Controlling a number of general hospitals, it is the first Hong Kong listed company committed to the professional healthcare investment and hospital management in mainland China. The Whole Care Hospital Management Co., Ltd., as a subsidiary of Huaxia Healthcare, is established according to the advanced international hospital management philosophy and scientific processes. Aimed at creating the "first-class international hospital management agency in China", it provides forward-looking, effective and creative solutions and systematical services for the rapid development of China's medical and healthcare industry. As the subsidiary in the pharmaceutical industry, Wanjia Group Holdings Limited (401.HK) is not only a company listed on the main board of Hong Kong Stock Exchange, but also a famous large company participating in drug sales and distribution in China, with a layout of the whole industry including pharmacy chain, logistics & wholesale and the hospital net sales.

Shenzhen BGI Science and Technology Co., Ltd.

As the" Chinese part " of the international Human Genome Project started , BGI was founded in Beijing on September 9, 1999. In 2007, seizing the opportunity of the new technological breakthroughs, BGI established the BGI Research in Shenzhen, and later set up other branches in Hong Kong, America, Europe and Japan, enlarging its business throughout the world. With a vision of "Trans-omics for a better life", it is dedicated to promoting the development of the biotechnology industry. Up till now, BGI has formed a model of mutual development in science, technology and industry and built a world-class team combining production, teaching and research. Besides, a series of genomic researches on the important flora and fauna, human health, microbiology, marine biology, bio-energy,etc. has been conducted.

Shanghai Sino-balan Investment Group Co., Ltd.

Shanghai Sino-balan Investment Group Co., Ltd. is a company mainly specialized in medical and steel investment and management. Now, the largest project of Sino-balan Investment Group is Zhejiang Xinan International Hospital and Fujian Xinan International Hospital. In addition to the investment and management of hospitals, Shanghai Sino-balan Investment Group also invested in steel, timber and real estate in the Southeast Asian countries, which makes it gradually become a diversified investment company. As one of China's leading private medical investment groups, it has a mission of promoting medical investment and management. With the internationally standardized management methods and modern hospital management philosophy, this group provides hospital management and professional management services under various systems and specialize in the investment, construction and management of hospitals, medical centers, nursing homes, rehabilitation centers .

Beijing Wuzhou Investment Group Co., Ltd.

Beijing Wuzhou Investment Group is a diversified international investment institution developed with globalization. Oriented to the health industry and involved in the field of international automobile trade, international mining, basic energy and large-scale e-commerce, it is also a leading Chinese industrial investment company, always upholding the philosophy of "high-end, high-quality and sustainable investment". It is committed to creating value for customers, opportunities for staff, profits for shareholders, wealth for the community and a capital platform with everlasting culture value, through investing in the high-quality oriented industry.

This group has successfully built a dozen of strong and influential brands- Wuzhou Maternal and Child Hospital chains, Munion Medical Cosmetology Hospital chains, Mary's Hospital chains, Pearl Stomatology Hospital chains, Wisdom-and-Virtue Intelligence Agency, Doctor-Search Network Technology Company, Amoy Pakistani music (China), as well as the international companies such as Promax Auto Trading Company in Canada and Vientiane Steel Industry Co., Ltd in Laos. The number of professional service and management personnel it has cultivated is about 13,588 and the industries it has invested in covers 78 Chinese cities such as Beijing, Shanghai, Chongqing, Shijiazhuang, Hohhot, Taiyuan , Xi'an, Qingdao and some oversea cities.


Pearl Medical Investment Group Co., Ltd.

Pearl International Dental Chain Medical Institutions are a set of diversified medical investment entities integrated with medical services, investment and development. Since 2001 when it was involved in the Chinese medical investment businesses, it has started a new era in the medical investment cooperation, the output of which has exceeded 3 billion yuan. Up till now, there has been over a hundred subordinate or directly managed medical institutions, in the major cities and developed economic zone throughout China. In 2001, it acquired 15% stake of the European, "Pearl Dental". In 2007, it achieved a full acquisition of the "Pearl Dental", and at the same time, it started from cooperated stomatology hospitals in China and gradually transformed into self-built stomatology hospitals. In 2011, it officially launched the industry chain's layout of "Pearl International Dental Chain Medical Institutions" in China. In the next 5 to 10 years, Pearl Dental will strive to build 100 high-end stomatology hospital as the leaders, mid-to-high-end dental clinics and health clubs as the support and universal dental clinics as the basis in the Chinese mainland, develop into not only an international good-quality dental chain medical institution but also a listed company based on the Yangtze River Delta, Pearl River Delta and Bohai Bay Economic Zone. The company has already set up a number of Pearl International Dental Chain Medical Institutions in Beijing, Shanghai, Guangzhou, Xi'an, Jinan, Chengdu and some other places in China .

Beijing People's Hospital Investment Management Co., Ltd.

People Group is a large group integrated with investment, medical services, equipment, technology and media, headquartered in Beijing. It has invested in different areas throughout the country, mainly in Beijing, Shanghai, Tianjin, Shandong, Zhejiang, Jiangsu, Fujian, and Guangdong, etc. This group is aimed to provide a full range of health management for the Chinese people, to provide medical equipment distribution with good quality and affordable price for all types of hospitals, to provide multiple levels of media campaigns and strong support of the expert team for the medical institutions and to provide rational and forward-looking investment and financing services for the medical & healthcare sector. With the joint efforts of the group of both top management and the junior employees, the People Group, strictly following the trend of Chinese healthcare development, and providing sincere services for all the Chinese people, is expanding continuously and developing vigorously.

Harmonicare Medical Holding Co., Ltd.

Harmonicare Medical Holding Co., Ltd. (Stock Code:HK.01509) has been engaged in medical investments, hospital management and medical brand operating fields. As China's largest holding private chain women and children hospital, it owns a total of 11 hospitals in Beijing, Shenzhen, Guangzhou, Chongqing and other cities, and employs more than 1000 outstanding doctors to serve our customers. We were listed on the main board in Hong Kong Exchange on July 7. Mr. Lin Yuming, Harmonicare Medical’s Chairman of the Board of Directors and President, said Harmonicare Medical is committed to becoming a leader in China’s high-end medical service market.

Yuanda International (Medical) Investment Group Co., Ltd.

Yuanda International (Medical) Investment Group Co., Ltd., is a modern group in the medical and healthcare industry, with medical investment, hospital management and clinical services as its core business, and with a layout in the medical-related fields including medicines, medical equipment, training, media, networks, etc. Yuanda has eight brands specialized in the medical sector and cooperates to invest and hold more than 100 hospitals. With medical institutions in more than 80 cities across the country and nearly 30,000 employees, it earns a annual revenue of nearly 50 billion yuan. Motivated by the national "new medical reform" policies, Yuanda has cooperated with the government to built new hospitals and taken an active part in participating in the reform of the public hospital system, which makes it one of China's fastest growing the medical industry groups with social capital.

Angel Group (China) Holding Co., Ltd.

Angel Group (China) Holding Co., Ltd. is an investment group dedicated to “providing excellent medical service and creating a perfect healthy world for mothers and babies". Since its inception, the Group adheres to the core value: "value life, emphasize profession, love others and do the best”. We set up our maternity hospitals under the international JCI standards. In June 2012, the Gaopan branch of Angel Maternal and Child Healthcare Hospital in Chengdu officially got the international JCI certification and became the 15th hospital in this standard in China, and the only one in the south-west district, opening a new chapter in integrating into the international-standard medical service.

Heng Yi Investment Group (China) Co., Ltd.

Heng Yi Investment Group (China) Co., Ltd is a joint-stock Medical Industry Investment Management Group, based on the investment management of hospital and new technology development in specialist areas, hospital information management, hospital commissioned operation and management, franchise chain, medical devices and pharmaceutical research and development, production and sales. It is a professional medical health management and investment group, which rolls the upper, middle and lower reaches of services in to one.

Shanghai Hongkang Hospital Management Co., Ltd.

Shanghai Hongkang hospital is approved by the Shanghai Municipal Health Bureau as a modern general hospital with characteristic diagnosis and treatment, and it is one of Shanghai City sentinel health units (hospitalization insurance and medical insurance) and a unit of Shanghai price integrity Construction. HongKang Hospital is located at No. 1933, Daduhe Road in Putuo District, Shanghai. The building has 11 layers and covers an area of 15800 square meters. The hospital absorbs a number medical experts and medical research team with rich clinical experience. It also invests heavily in striving to introduce the sophisticated technology and equipment, and striving to be equipped with more hardware and software in order to be one of characteristic general hospital in Shanghai.

Sheng Kang International Group Co., Ltd.

Sheng Kang International Group Co., Ltd. is an investment management group of comprehensive international health industry, oriented in developing specialty brand chain hospitals and large international hospitals. It consists of a number of corporate entities and dozens of hospitals all over the country. The number of staff is more than 6,000, with hundreds of senior titled doctors. In 2011, the company established a construction project to build Elizabeth international maternity hospital in the International Medical Park of Pudong District, Shanghai. The hospital is expected to be invested around $2 billion, covering an area of 82 acres, planning to hold 400 beds. It has been approved to the title of "international" by Ministry of Health, and given the official approval by Shanghai Municipal Health Bureau for the establishment and is now under construction. The hospital has reached an agreement of cooperation intention with Oxford University and global top maternity medical institutions. After the completion, it will invite the world's famous doctors, committed to creating a model of China's high-end maternity hospital.

International Hospitals Group Co., Ltd. (IHG)

International Hospitals Group (IHG) is the world's most experienced international health care company that provides the global hospitals and other medical service agencies with professional medical advice, hospital construction contracting, medical equipment assembly and operation management services. IHG was established in 1978 and headquartered in the United Kingdom. It is an international medical service group which have successfully completed over 450 private and public health programs in more than 50 countries. Our customers include 22 national governments, the UN, the World Bank and international financial organizations. Since its inception, IHG has recruited and trained more than 15,000 professional staff. Besides, it has always been supported by the British government as well as various types of professionals in more than 150 countries. These professionals have got not only rich experience in the medical industry but also the professional training in the world's largest medical organizations - the British National Health Service (NHS) (the annual budget of which is more than 120 billion pounds).

Zhejiang Helowin Medical Technology Co., Ltd.

Zhejiang Helowin Medical Technology Co., Ltd. is the first high-tech enterprise focusing on the product development, production and sales of “mobile smart medical treatment” and it is one of the pioneers of the Internet of Things (IOT) medical technology development and industrialization application researches in the domestic. The company was established in 2006 with the registered capital of RMB 29,629,629. The company upholds the “three high strategy”: high starting point, high technology and high standard, and takes advantage of technology, capital, management, marketing, creating a new field of domestic mobile smart medical treatment. Under the guidance of the academicians and experts in the famous domestic hospitals and in the long-term cooperation with the the Pervasive Institute of Chinese Academy of Science, the IOT has perfectly combined the professional medical technology with the wireless remote monitor diagnosis and treatment via the technology improvement and project development and it has successfully applied to the mobile medical treatment information and IOT medical and healthcare filed. By collecting various human physiological parameters, the product makes a real-time transmission of these data to the remote central monitoring service platform, and the platform will make an automatic statistics, analysis and process of them, providing the diagnosis assistance of various important of physiological parameter information for the professional medical staffs. Up till now, Helowin products have gotten nearly 60 patents and computer software work copyrights in this field, which is in the forefront of domestic industry.

Baijia International Group Co., Ltd.

Baijia International Group is a professional medical chain for maternal and infant healthcare invested by Morgan Stanley and Bluepoint Medical, dedicated to developing the high-end market of maternal and infant healthcare in Greater China, investing and managing the maternal and infant healthcare industrial park. As the leading company in the maternal and infant healthcare industry, with the spirit of "advocating natural childbirth and enjoying international healthcare", it has already successfully invested in many medical chains for maternal and infant healthcare, covering 17 cities such as Shanghai, Hangzhou, Wenzhou, Guangzhou, Dongguan, Changsha, Nanchang, Hefei, Wuhan, Jinan, etc. Since that, it has earned a wide range of social awareness and high reputation in the Yangtze River Delta, Pearl River Delta and the city groups in the central area. Baijia takes the evaluation criteria of the Joint Commission International (JCI) as the management standard, and introduces the FCWI model of mental and physical health care, provides the "3H" services integrated the high-quality medical services of hospital, star-ranked humanistic services of hotel with the warm and cordial service of home. This has become a distinctive brand feature for all the maternal and infant healthcare chains, which not only meets the specialized needs for serving the high-end customers, but also develops a unique maternal and infant healthcare system. With a multi-national elite medical expert team, it has developed a long-term cooperation with the world-renowned medical institutions and become one of the best providers of maternal and infant healthcare service in the international high-end market.

Boai (China) Enterprise Group, P.R

Boai (China) Enterprise Group, P.R. owns nine groups including Guangdong Boai Medical Group, Shenzhen Boai Medical Group, Shanghai Visionary Hospital Group, Nianlun Orthopedics Hospital Group, Vietnam Boai Medical Group, which invest, manage and operate more than 100 medical institutions including Shenzhen Boai Hospital, Shenzhen Shuguang Hospital, Shenzhen Wuzhou Hospital of Integrated Chinese and Western Medicine, Shenzhen Far-East Women & Children Hospital, Guangzhou Chang'an Hospital, Guangzhou Modern Hospital, Shanghai Ren-ai Hospital, Shanghai Yodak Cardiothoracic Hospital, Shanghai Tianda Munion Medical Cosmetology Hospital, Shanghai Hoosen E.N.T & Stomatology Hospital, Guangzhou Meyo Hospital, Hanoi Reproductive Health Center, Hoan Kiem Multidisciplinary Clinic and Ho Chi Minh International Medical Centre (CMI) in Vietnam. Business involves ten areas of expertise, including cardiothoracic surgery, maternal and child care, plastic surgery, orthopedics, oncology, E.N.T, stomatology, ophthalmology, genesiology and health management. The hospital not only has the leading medical technology and experience, but also cultivate medical humanities. With a number of domestic and foreign medical experts and the introduction of world-class technology and equipment, it has carried out various featured medical services and made academic exchanges with the World Health Organization (WHO), the Ministry of Health, well-known hospitals, research institutes and universities at home and abroad, which has a great international influence.